Home › Funds › PFM Health Sciences, LP › CNMD
PFM Health Sciences, LP position in CNMD
CONMED CORP · Health Care
PFM Health Sciences, LP reported holding 324,246 shares of CNMD (CONMED CORP) in its Q3 2026 13F filing — a position valued at US$15.0M, representing 1.53% of its reported portfolio and ranking #22 among its reported holdings. PFM Health Sciences, LP first reported this position in Q3 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How PFM Health Sciences, LP's CNMD position evolved
PFM Health Sciences, LP first disclosed a stake in CNMD in Q3 2026 at 324,246 shares (US$15.0M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 324.25K | $14.99M | New |
About CNMD and 13F data
CNMD (CONMED CORP) is a Health Care company. 16 other funds we track also report a position in CNMD — the largest reported positions include OAKTREE CAPITAL MANAGEMENT LP (US$52.5M), Invenomic Capital Management LP (US$27.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CNMD
- OAKTREE CAPITAL MANAGEMENT LP 53.65M sh · $52.46M · Q2 2026
- Invenomic Capital Management LP 842.16K sh · $27.56M · Q2 2026
More on PFM Health Sciences, LP
FAQ
How long has PFM Health Sciences, LP held CNMD?
PFM Health Sciences, LP has disclosed CNMD holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is PFM Health Sciences, LP's current position in CNMD?
As of Q3 2026, PFM Health Sciences, LP holds 324.25K shares of CNMD (CONMED CORP), valued at $14.99M, representing 1.53% of its reported portfolio and ranking #22.
Has PFM Health Sciences, LP been buying or selling CNMD?
In the latest 13F filing (Q3 2026), PFM Health Sciences, LP newly opened its position in CNMD.
Which other funds hold CNMD?
Other major institutional holders of CNMD include OAKTREE CAPITAL MANAGEMENT LP, Invenomic Capital Management LP, among 16 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.